Genetic Markers Associated to Dyslipidemia in HIV‐Infected Individuals on HAART
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wiley in The Scientific World Journal
- Vol. 2013 (1) , 608415
Abstract
This study evaluated the impact of 9 single nucleotide polymorphisms (SNPs) in 6 candidate genes (APOB, APOA5, APOE, APOC3, SCAP, and LDLR) over dyslipidemia in HIV‐infected patients on stable antiretroviral therapy (ART) with undetectable viral loads. Blood samples were collected from 614 patients at reference services in the cities of Porto Alegre, Pelotas, and Rio Grande in Brazil. The SNPs were genotyped by conventional polymerase chain reaction (PCR) and real‐time PCR. The prevalence of dyslipidemia was particularly high among the protease inhibitors‐treated patients (79%). APOE (rs429358 and rs7412) genotypes and APOA5 −1131T>C (rs662799) were associated with plasma triglycerides (TG) and low‐density‐lipoprotein cholesterol levels (LDL‐C). The APOA5 −1131T>C (rs662799) and SCAP 2386A>G (rs12487736) polymorphisms were significantly associated with high‐density‐lipoprotein cholesterol levels. The mean values of the total cholesterol and LDL‐C levels were associated with both the APOB SP Ins/Del (rs17240441) and APOB XbaI (rs693) polymorphisms. In conclusion, our data support the importance of genetic factors in the determination of lipid levels in HIV‐infected individuals. Due to the relatively high number of carriers of these risk variants, studies to verify treatment implications of genotyping before HAART initiation may be advisable to guide the selection of an appropriate antiretroviral therapy regimen.Keywords
This publication has 40 references indexed in Scilit:
- HIV and HAART-Associated DyslipidemiaThe Open Cardiovascular Medicine Journal, 2011
- Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination SurveyBMC Medical Genetics, 2010
- Contribution of Genome-Wide Significant Single-Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected IndividualsCirculation: Cardiovascular Genetics, 2009
- Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAARTHIV Medicine, 2009
- Common variants at 30 loci contribute to polygenic dyslipidemiaNature Genetics, 2008
- LDL-cholesterol concentrations: a genome-wide association studyThe Lancet, 2008
- Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and DyslipidemiaThe American Journal of Human Genetics, 2008
- Protease Inhibitor-Associated Dyslipidemia in HIV-Infected Patients Is Strongly Influenced by the APOA5–1131T→C Gene VariationClinical Chemistry, 2006
- Modeling the Influence ofAPOC3, APOE,andTNFPolymorphisms on the Risk of Antiretroviral Therapy–Associated Lipid DisordersThe Journal of Infectious Diseases, 2005
- Dramatic improvement in survival among adult Brazilian AIDS patientsAIDS, 2003